Filter posts

BIO’s Dave Thomas Talks VC Funding with Daniel Levine

Last week, BIO Industry Analysis’s Dave Thomas spoke with Daniel Levine for his weekly podcast, …

BIO Accepting Nominations for its Award Honoring One Outstanding Woman in Industrial Biotech

Today, BIO announced that it has officially extended its deadline for the Rosalind Franklin Award for …

Nasdaq Social Bell: Twitter Strategies For Biotechs

Last week at the BIO CEO & Investor Conference in New York City, I had …

Deal Structures: More Options for Companies

By most measures, 2014 was a great year for the biotechnology industry. Venture capital deal …

Ten Years of Therapeutic Venture Capital

What therapeutic areas have received the most funding in private drug companies over the last …

Forbes Asks: Should Economists Perform Surgery and Doctors Conduct Economic Policy?

Over at Forbes, University of Chicago economist Tomas Philipson has an insightful post analyzing several …

Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey

Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and …

Exclusive FDA Survey Webinar

BIO is conducting an exciting new survey designed to measure FDA/Sponsor Interactions During Drug Development.  …

The Eyes Have It According to Recent VC Funding Patterns

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …

Back to School: Consider a STEM Career

With school resuming for many throughout the country this week, one question that may be …